Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 26, 2007

Investigators Find Link Between Saethre-Chotzen Syndrome and Breast Cancer

  • Scientists at the Lundberg Laboratory for Cancer Research and the Plastic Surgery Clinic at the Sahlgrenska Academy in Sweden say they have discovered a new hereditary breast cancer gene. The researchers found that women with Saethre-Chotzen syndrome, caused by th gene TWIST1, are nearly 20 times more at risk of contracting breast cancer than expected.

    The investigators mapped families with Saethre-Chotzen syndrome. This condition primarily involves malformations of the skull, face, hands, and feet. 

    The scientists are planing various experiments to chart the mechanism of how TWIST1 increases the risk of breast cancer. The results of this study appear in Genes Chromosomes Cancer.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »